- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Bronchospasm
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Terbutaline – July 2019
Terbutaline: Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 100 doses; Bricanyl Turbuhaler®
Last updated
9 July 2025